BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37216165)

  • 61. [Analysis of prognostic factors after radical resection in 628 patients with stage II or III colon cancer].
    Qin Q; Yang L; Zhou AP; Sun YK; Song Y; DU F; Wang JW
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):212-6. PubMed ID: 23880003
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prognostic significance of tumor-infiltrating lymphocytes may differ depending on Ki67 expression levels in estrogen receptor-positive/HER2-negative operated breast cancers.
    Fujimoto Y; Watanabe T; Hida AI; Higuchi T; Miyagawa Y; Ozawa H; Bun A; Fukui R; Sata A; Imamura M; Hirota S; Miyoshi Y
    Breast Cancer; 2019 Nov; 26(6):738-747. PubMed ID: 31098866
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Association of Tumor-Associated Collagen Signature With Prognosis and Adjuvant Chemotherapy Benefits in Patients With Gastric Cancer.
    Chen D; Chen H; Chi L; Fu M; Wang G; Wu Z; Xu S; Sun C; Xu X; Lin L; Cheng J; Jiang W; Dong X; Lu J; Zheng J; Chen G; Li G; Zhuo S; Yan J
    JAMA Netw Open; 2021 Nov; 4(11):e2136388. PubMed ID: 34846524
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The impact of kidney function on colorectal cancer patients with localized and regional diseases: An observational study from Taiwan.
    Chiang SF; Chen JS; Tang R; Yeh CY; Hsieh PS; Tsai WS; You JF; Hung HY; Lai CC; Lin JR; Chiang JM
    Indian J Cancer; 2019; 56(3):241-247. PubMed ID: 31389388
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Adjuvant Chemotherapy Improves Survival in Stage III Gastric Cancer after D2 Surgery.
    Chang SC; Liu KH; Hung CY; Tsai CY; Hsu JT; Yeh TS; Chen JS; Kuo YC; Hung YS; Chou WC
    J Cancer; 2018; 9(1):81-91. PubMed ID: 29290772
    [No Abstract]   [Full Text] [Related]  

  • 66. Comparison of the prognostic value of genomic grade index, Ki67 expression and mitotic activity index in early node-positive breast cancer patients.
    Bertucci F; Finetti P; Roche H; Le Doussal JM; Marisa L; Martin AL; Lacroix-Triki M; Blanc-Fournier C; Jacquemier J; Peyro-Saint-Paul H; Viens P; Sotiriou C; Birnbaum D; Penault-Llorca F
    Ann Oncol; 2013 Mar; 24(3):625-32. PubMed ID: 23117074
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Final 10-year results of the Breast International Group 2-98 phase III trial and the role of Ki67 in predicting benefit of adjuvant docetaxel in patients with oestrogen receptor positive breast cancer.
    Sonnenblick A; Francis PA; Azim HA; de Azambuja E; Nordenskjöld B; Gutiérez J; Quinaux E; Mastropasqua MG; Ameye L; Anderson M; Lluch A; Gnant M; Goldhirsch A; Di Leo A; Barnadas A; Cortes-Funes H; Piccart M; Crown J
    Eur J Cancer; 2015 Aug; 51(12):1481-9. PubMed ID: 26074397
    [TBL] [Abstract][Full Text] [Related]  

  • 68. ERCC1, defective mismatch repair status as predictive biomarkers of survival for stage III colon cancer patients receiving oxaliplatin-based adjuvant chemotherapy.
    Li P; Fang YJ; Li F; Ou QJ; Chen G; Ma G
    Br J Cancer; 2013 Apr; 108(6):1238-44. PubMed ID: 23481186
    [TBL] [Abstract][Full Text] [Related]  

  • 69. High Ki67/BCL2 index is associated with worse outcome in early stage breast cancer.
    Min KW; Kim DH; Do SI; Pyo JS; Chae SW; Sohn JH; Kim K; Lee HJ; Kim DH; Oh S; Choi SH; Park YL; Park CH; Kwon MJ; Moon KM
    Postgrad Med J; 2016 Dec; 92(1094):707-714. PubMed ID: 27222586
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prognostic Factors for Luminal B-like Breast Cancer.
    Ding NH; Liu CF; Hu C; Yuan JQ; Liao WH; Xiao Z
    Curr Med Sci; 2019 Jun; 39(3):396-402. PubMed ID: 31209809
    [TBL] [Abstract][Full Text] [Related]  

  • 71. ACRNaCT trial protocol: efficacy of adjuvant chemotherapy in patients with clinical T3b/T4, N+ rectal Cancer undergoing Neoadjuvant Chemoradiotherapy: a pathology-oriented, prospective, multicenter, randomized, open-label, parallel group clinical trial.
    Li Q; Luo D; Zhu J; Yang L; Liu Q; Ma Y; Liang L; Cai S; Zhang Z; Li X;
    BMC Cancer; 2019 Nov; 19(1):1117. PubMed ID: 31729964
    [TBL] [Abstract][Full Text] [Related]  

  • 72. High Expression of CUL9 Is Prognostic and Predictive for Adjuvant Chemotherapy in High-Risk Stage II and Stage III Colon Cancer.
    Zheng P; Lv Y; Mao Y; Shen F; Zhang Z; Chang J; Yu S; Ji M; Feng Q; Xu J
    Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010837
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Perineural Invasion Is a Prognostic but not a Predictive Factor in Nonmetastatic Colon Cancer.
    Leijssen LGJ; Dinaux AM; Taylor MS; Deshpande V; Kunitake H; Bordeianou LG; Berger DL
    Dis Colon Rectum; 2019 Oct; 62(10):1212-1221. PubMed ID: 31490830
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Association between Ki67 Index and Clinicopathological Features in Colorectal Cancer.
    Li P; Xiao ZT; Braciak TA; Ou QJ; Chen G; Oduncu FS
    Oncol Res Treat; 2016; 39(11):696-702. PubMed ID: 27855388
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Immunohistochemical analysis of PTEN, HER2/neu, and ki67 expression in patients with gastric cancer and their association with survival.
    Badary DM; Abdel-Wanis ME; Hafez MZ; Aboulhagag NA
    Pathophysiology; 2017 Jun; 24(2):99-106. PubMed ID: 28262306
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The potential utility of geminin as a predictive biomarker in breast cancer.
    Sundara Rajan S; Hanby AM; Horgan K; Thygesen HH; Speirs V
    Breast Cancer Res Treat; 2014 Jan; 143(1):91-8. PubMed ID: 24292956
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Correlation of Preoperative Ki67 and Serum CA15.3 Levels with Outcome in Early Breast Cancers a Multi Institutional Study.
    Rasmy A; Abozeed W; Elsamany S; Baiomy ME; Nashwa A; Amrallah A; Hasaan E; Alzahrani A; Faris M; Alsaleh K; AlFaraj A
    Asian Pac J Cancer Prev; 2016; 17(7):3595-600. PubMed ID: 27510014
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The prognostic significance of p53, p27 kip1, p21 waf1, HER-2/neu, and Ki67 proteins expression in gastric cancer: a clinicopathological and immunohistochemical study of 121 Arab patients.
    Al-Moundhri MS; Nirmala V; Al-Hadabi I; Al-Mawaly K; Burney I; Al-Nabhani M; Thomas V; Ganguly SS; Grant C
    J Surg Oncol; 2005 Sep; 91(4):243-52. PubMed ID: 16121348
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Correlation Analysis of Ki67 Expression and EGFR Mutation on the Risk of Recurrence and Metastasis in Postoperative Patients with Stage I Lung Adenocarcinoma].
    Xu L; Guo R
    Zhongguo Fei Ai Za Zhi; 2022 Dec; 25(12):852-861. PubMed ID: 36617471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.